psalexa
logo

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors Pipeline Analysis

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments

Published: April 2017
Report Code: LS10812
Available Format:
Pages: 155

Note: This report can also be updated as of date and delivered within 1-2 workings days of purchase confirmation

This report includes the pipeline analysis to estimate and analyze the emerging therapies and their progress status in different phases of development. The report also contains competitive analysis and extensive information on monotherapies, combination therapies, targets and mechanism of action and drug origin with relevance to PI3K inhibitors.

PI3K Inhibitors Pipeline Analysis

  • By Phase
    • Phase III
    • Phase II
    • Phase I
    • Pre-Clinical
    • Discovery
  • By Route of Administration
    • Oral
    • Intravenous
    • Others
    • Not Disclosed
  • By Target
    • PI3K inhibitor
    • PI3K delta inhibitor
    • PI3K alpha inhibitor
    • Others
  • By Company

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 2500
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 3250
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7000

Pre-Purchase Enquiry